Dimension | All () | ISS () | SGA () | |
---|---|---|---|---|
Age at T1 | Years | 6.07 2.45 () | 6.21 2.37 () | 5.42 2.78 () |
Age at T2 (years) | years | 7.88 2.73 () | 8.06 2.65 () | 7.29 2.92 () |
Height at T1 | SDS | 2.83 0.69 | 2.72 0.54 | 3.32 0.94 |
Height at T2 | SDS | 2.66 0.61 | 2.53 0.42 | 3.26 0.91 |
Delta height gain | SDS | 0.08 0.2 | 0.1 0.19 | 0.02 0.24 |
Target height | SDS | 0.65 0.57 | 0.66 0.53 | 0.63 0.72 |
Ht at T2 minus THT | SDS | 2.01 0.73 | 1.87 0.56 | 2.63 1.06 |
Below target range | ( %) | 85 (74.6%) | 68 (73%) | 17 (81.0%) |
BA-CA | years | 1.54 1.06 | 1.61 1.06 | 1.26 1.05 |
PAH | SDS | 1.83 1.08 () | 1.71 1.05 () | 2.4 1.09 () |
Ht-PAH | SDS | 0.71 1.01 () | 0.76 ± 1.02 () | 0.48 0.97 () |
Ht SDSPAH SDS | ( %) | 43 (75%) | 37 (79%) | 6 (60%) |
PAH-THT | SDS | 1.14 1.12 () | 1.01 1.18 () | 1.78 0.96 () |
PAH SDStarget range | (,%) | 13 (22.8%) | 9 (19.1%) | 4 (40%) |
IGF-I | SDS | 1.21 0.82 | 1.29 0.82 | 0.85 0.73 |
IGF-I 2 | (,%) | 19 (16.7%) | 18 (19.4%) | 1 (4.8%) |
IGFBP-3 | SDS | 0.19 0.94 () | 0.12 0.95 () | 0.52 0.81 () |
IGFBP-3 SDS 2 | ( %) | 8 (7.3%) | 6 (6.7%) | 2 (10.5%) |